A new phenolic amide 8, together with the nine known phenolic compounds 1-7, 9 and 10 were isolated from the MeOH extract of the roots of Paris verticillata. The structure of the new compound 8 was determined to be 1-N-feruloylaminobutyl-4-ρ-hydroxybenzamide by spectroscopic methods. The isolated compounds were tested for cytotoxicity against four human tumor cell lines using the SRB assay.
Introduction
The perennial herb Paris veriticillata BIEB. (Liliaceae) is found in Korean valleys and has been used in Korean folk medicine as a treatment for asthma and chronic bronchitis [1] . Steroids and flavonol glycosides have been isolated from P. verticillata [2] . In continuation of our search for biologically active compounds from Korean medicinal plant sources, we have investigated the constituents of the roots of P. verticillata. Repeated column chromatographic separation of the MeOH extract of this plant led to the isolation of a new phenolic amide 8, as well as nine known phenolic constituents (1 -7, 9 and 10, Figure 1 ). The known compounds are reported from this plant source for the first time. This paper deals with the isolation of the phenolic constituents, their cytotoxicity and the structure determination of the new phenolic amide.
Results and Discussion
The known compounds ( Figure 1 ) were identified as methyl 3,4-dihydroxybenzoate (1) [3] , methyl caffeoate (2) [4] , rosmarinic acid (3) [5] , globoidnan A (4) [6] , salireposide (5) [7] , xylosmacin (6) [8] , trichocarpin (7) [9] , methyl rosmarinate (9) [5] and caffeic acid (10) [10] by comparing their spectroscopic data with those reported in the literature. 
Biological activity
The isolated compounds were tested for cytotoxicity against four human tumor cell lines using the sulforhodamin B (SRB) assay. Compounds 1, 2, 4 and 9 showed mild cytotoxicity against only SK-OV-3 (ovary malignant ascites), with ED 50 values of 10.14, 9.13, 12.27 and 7.22 μM, respectively. The other compounds exhibited little activity (ED 50 > 30 μM) against the tested cancer cell lines.
Experimental
General NMR spectra were recorded on a Varian Unity Inova 500Nb spectrometer. MS spectra were recorded on a JEOL JMS-700 mass spectrometer. Preparative HPLC used a Knauer K1001 instrument equipped with a refractive index detector, a UV detector and an Econosil silica 5 μm column (length: 250 mm, I.D 22 mm, Alltech) and an Econosil C 18 
Extraction and Isolation
The dried and chopped root of P. verticillata (1.5 kg) was extracted three times with MeOH at room temperature. The MeOH extract (180 g) was suspended in distilled water (1.6 L) and successively partitioned with n-hexane, CH 2 Cl 2 , EtOAc and n-butanol, followed by evaporation, to yield 5.2, 3.5, 4.4 and 20 g fractions, respectively. The EtOAc fraction (4.4 g) was chromatographed over a silica gel column using a gradient solvent system (CHCl 3 -MeOH = 5:1 → 0:1) to give five subfractions (E1-E5). The E1 fraction (0.2 g) was chromatographed over silica gel (CHCl 3 -MeOH = 10:1), Sephadex LH-20 filtration (MeOH) and purified using HPLC (RP C-18 resin, 30% MeOH) to yield 1 (7 mg) and 2 (15 mg). The E2 fraction (1.4 g) was chromatographed over RP C-18 resin (50% MeOH), silica gel (CHCl 3 -MeOH = 7:1) and purified using HPLC (RP C-18 resin, 45% MeOH) to yield 3 (15 mg), 4 (4 mg), 5 (5 mg), 6 (6 mg) and 7 (5 mg). The E3 fraction (1.2 g) was chromatographed over silica gel (CHCl 3-MeOH = 10:1), LPLC (RP C-18 resin, 40% MeOH) and purified using HPLC (silica gel, hexane-CHCl 3 -MeOH = 3:5:1 and 2:5:1) to yield 8 (4 mg), 9 (25 mg) and 10 (34 mg). (8) 
Spectroscopic data for 1-N-feruloyl-aminobutyl-4-ρ-hydroxybenzamide

Test for in vitro cytotoxicity.
A sulforhodamin B bioassay (SRB) was used to determine the cytotoxicity of each compound against four cultured human cancer cell lines [11] . The assays were performed at the Korea Research Institute of Chemical Technology. The cell lines used were A549 (non small cell lung carcinoma), SK-OV-3 (ovary malignant ascites), SK-MEL-2 (skin melanoma) and HCT (colon adenocarcinoma).
